BioSymetrics, an artificial intelligence and machine learning SaaS company, announced yesterday that it has named Dr Calum MacRae as its new senior advisor.
Dr MacRae is a pioneer in genetics, biology, and drug discovery. He will assist BioSymetrics in the design and application of the company's software for use in drug discovery, precision medicine and health systems.
He is the vice chair for Scientific Innovation at the Department of Medicine at Brigham and Women's Hospital and associate professor of medicine at Harvard Medical School. He is also the leader of the One Brave Idea initiative, a diverse team of scientists, together with the latest technologies and scientific advances, with a mission to find the weapons and strategies to win the fight against coronary heart disease.
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Enable Biosciences names new chief financial officer
Cadenza Bio names new director
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation